Nuwellis, Inc. financial data

Symbol
NUWE on Nasdaq, NUWEW on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
12988 Valley View Road, Eden Prairie, MN
State of incorporation
DE
Fiscal year end
December 31
Former names
CHF Solutions, Inc. (to 4/16/2021), Sunshine Heart, Inc. (to 5/23/2017)
Latest financial report
10-K - Q4 2024 - Mar 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 179 % -47.6%
Quick Ratio 56.5 % -18.8%
Debt-to-equity 684 % +1151%
Return On Equity -1.19K % -423%
Return On Assets -152 % -3.64%
Operating Margin -126 % +36.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.37M shares -35.7%
Common Stock, Shares, Outstanding 4.37M shares +2601%
Entity Public Float 1M USD -80%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 1.33M shares +2265%
Weighted Average Number of Shares Outstanding, Diluted 1.33M shares +2265%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8.74M USD -1.4%
Research and Development Expense 3.21M USD -40.8%
Operating Income (Loss) -11M USD +37.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.2M USD +44.8%
Income Tax Expense (Benefit) 5K USD -37.5%
Net Income (Loss) Attributable to Parent -11.2M USD +44.8%
Earnings Per Share, Basic -8.41 USD/shares +97.7%
Earnings Per Share, Diluted -8.41 USD/shares +97.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.1M USD +34.1%
Accounts Receivable, after Allowance for Credit Loss, Current 1.73M USD -11.5%
Inventory, Net 1.72M USD -14%
Other Assets, Current 315K USD -31.7%
Assets, Current 8.86M USD +7.87%
Property, Plant and Equipment, Net 478K USD -34.3%
Operating Lease, Right-of-Use Asset 510K USD -28.5%
Other Assets, Noncurrent 21K USD -82.5%
Assets 9.86M USD +0.96%
Employee-related Liabilities, Current 640K USD +21.9%
Liabilities, Current 2.56M USD -19.3%
Operating Lease, Liability, Noncurrent 307K USD -43.6%
Liabilities 3.33M USD -49.2%
Retained Earnings (Accumulated Deficit) -299M USD -3.88%
Stockholders' Equity Attributable to Parent 6.53M USD +118%
Liabilities and Equity 9.86M USD +0.96%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.86M USD +53.1%
Net Cash Provided by (Used in) Financing Activities 500K USD
Net Cash Provided by (Used in) Investing Activities -29K USD +70.4%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.37M shares +2601%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.4M USD +61.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.1M USD +34.1%
Deferred Tax Assets, Valuation Allowance 54.3M USD +3.73%
Deferred Tax Assets, Gross 54.3M USD +3.73%
Operating Lease, Liability 545K USD -28.3%
Payments to Acquire Property, Plant, and Equipment 29K USD +123%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -11.2M USD +44.9%
Lessee, Operating Lease, Liability, to be Paid 584K USD -32.3%
Property, Plant and Equipment, Gross 4.26M USD +1.09%
Operating Lease, Liability, Current 238K USD +10.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 273K USD +3.41%
Lessee, Operating Lease, Liability, to be Paid, Year One 265K USD +3.11%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 39K USD -61.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 46K USD -83.1%
Deferred Tax Assets, Operating Loss Carryforwards 50.7M USD +3.96%
Preferred Stock, Shares Authorized 39.4M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 69K USD -74.6%
Additional Paid in Capital 305M USD +5.06%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 86K USD -18.1%
Share-based Payment Arrangement, Expense 478K USD -28.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%